Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma David A. Reardon , Alba A. Brandes , Antonio Omuro +17 more ClinicalTrials.gov Identifier: NCT02017717. 2020 JAMA Oncology 1314 citations